Skip to main content

Table 1 Cost of Afatinib, Erlotinib, and Gefitinib; and indicated dosage

From: Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

TKI Presentation Cost at which INCan bought one month of treatment Daily dose
Afatinib 30 tablets of 40 mg MXN 22,950.00 40 mg
Erlotinib 30 tablets of 150 mg MXN 24,560.40 150 mg
Gefitinib 30 tablets of 250 mg MXN 13,532.04 150 mg